Výsledky vyhledávání - "Kevin R. Frost"

Are We Hitting the Target? HIV Pre-Exposure Prophylaxis from 2012 to 2020 in the OPERA Cohort

Autor: Ricky Hsu, Jennifer S Fusco, Laurence Brunet, Vani Vannappagari, Mark S. Shaefer, Alex R. Rinehart, Keith M Rawlings, Kevin R. Frost, Karam Mounzer, Gregory Fusco

Publikováno v: AIDS patient care and STDs. 35(11)

Preventing HIV transmission is a crucial step in ending the HIV epidemic. Safe and effective pre-exposure prophylaxis (PrEP) has been available in the United States since 2012. We set out to determine if persons at greatest risk for HIV acquisition w

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef27a5ba2c10b0e2e850527b79df4d4c
https://pubmed.ncbi.nlm.nih.gov/34609897

Zobrazit plný text záznamu

Experience with the use of a first-line regimen of stavudine, lamivudine and nevirapine in patients in the TREAT Asia HIV Observational Database

Autor: Nicholas I. Paton, Kevin R. Frost, Adeeba Kamarulzaman, Praphan Phanuphak, Nagalingeswaran Kumarasamy, Y-M A Chen, Sanjay Pujari, Rossana Ditangco, Fujie Zhang, Matthew Law, Tuti Parwati Merati, John Chuah, David A. Cooper, Patrick C.K. Li, J. Zhou, Christopher K C Lee, Asda Vibhagool

Publikováno v: HIV Medicine. 8:8-16

Background The antiretroviral treatment (ART) combination of stavudine, lamivudine and nevirapine (d4T/3TC/NVP) is the most frequently used initial regimen in many Asian countries. There are few data on the outcome of this treatment in clinic cohorts

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::24daea38a6af7cb8c9d9f5212e798d63
https://doi.org/10.1111/j.1468-1293.2007.00417.x

Zobrazit plný text záznamu

The TREAT Asia HIV Observational Database

Autor: Fujie Zhang, Sanjay Pujari, Matthew Law, Praphan Phanuphak, David A. Cooper, Patrick C.K. Li, Christopher K C Lee, Asda Vibhagool, Nicholas I. Paton, John Chuah, Adeeba Kamarulzaman, Rossana Ditangco, Wing-Wai Wong, Kevin R. Frost, Nagalingeswaran Kumarasamy, Jialun Zhou

Publikováno v: JAIDS Journal of Acquired Immune Deficiency Syndromes. 38:174-179

Relatively little is known regarding HIV disease natural history and response to antiretroviral treatments among Asian people infected with HIV. The Therapeutics Research, Education, and AIDS Training in Asia (TREAT Asia) HIV Observational Database (

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::799c34f6bee8a3069ce96b517457ecea
https://doi.org/10.1097/01.qai.0000145351.96815.d5

Zobrazit plný text záznamu

Treatment of chronic hepatitis C in HIV/HCV-coinfection with interferon α-2b+ full-course vs. 16-week delayed ribavirin

Autor: Maurizio Bonacini, Kevin R. Frost, Jeffery J. Smith, Carol Giffen, Dale Prokupek, Maribel Rodriguez-Torres, Jay R. Kostman, Norbert Bräu

Publikováno v: Hepatology. 39:989-998

Human immunodeficiency virus (HIV)-infected patients increasingly experience the consequences of chronic hepatitis C virus (HCV) coinfection. This trial randomized 107 patients coinfected with HIV and HCV to receive 48 weeks of interferon alfa-2b (IF

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5336c189511e1ba39c5b710830b2d778
https://doi.org/10.1002/hep.20107

Zobrazit plný text záznamu

Trimethoprim‐Sulfamethoxazole (TMP‐SMZ) Dose Escalation versus Direct Rechallenge forPneumocystis CariniiPneumonia Prophylaxis in Human Immunodeficiency Virus–Infected Patients with Previous Adverse Reaction to TMP‐SMZ

Autor: Ramon A. Torres, Gifford S. Leoung, Ellen C. Cooper, Jeffery J. Smith, Kevin R. Frost, Valerie Dratter, Margaret N. Wesley, Michael F. Giordano, James F. Stanford, Allan Stein, Carol Giffen, Tricia Sarracco

Publikováno v: The Journal of Infectious Diseases. 184:992-997

Trimethoprim-sulfamethoxazole (TMP-SMZ) is the most effective Pneumocystis carinii pneumonia (PCP) prophylactic agent, but adverse reactions are common among human immunodeficiency virus (HIV)-infected patients and limit its use. This randomized, dou

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::55337f4761e8401a572c66be67c33292
https://doi.org/10.1086/323353

Zobrazit plný text záznamu

A Randomized Study of the Safety and Antiretroviral Activity of Hydroxyurea Combined with Didanosine in Persons Infected with Human Immunodeficiency Virus Type 1

Autor: Ramon A. Torres, George Perez, Gail Skowron, Kevin R. Frost, Alex N. Fleishman, Grace Accetta, Ellen C. Cooper, Shannon Schrader, Michael F. Giordano, James Hellinger, Calvin J. Cohen, Jeffery J. Smith, Marika K. Iwane

Publikováno v: The Journal of Infectious Diseases. 181:540-547

This randomized open-label trial of human immunodeficiency virus type 1-infected persons compared safety and efficacy for 38 patients receiving hydroxyurea/didanosine combination therapy with findings in 42 persons given didanosine monotherapy for 12

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::93ed18298fd7b874aab0758bca47fd9f
https://doi.org/10.1086/315231

Zobrazit plný text záznamu

A National HIV Community Cohort

Autor: Marika K. Iwane, Kevin R. Frost, Kevin J. Meagher, Calvin J. Cohen, Kenneth H. Mayer, David L. Levin, Jolie B. Palensky

Publikováno v: Journal of Clinical Epidemiology. 51:779-793

This article describes the design, methodology, baseline distributions, and general follow-up characteristics of the American Foundation for AIDS Research (AmFAR) National Observational Database (ODB) Project including the benefits and limitations of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::527712d82fec7a361e1119db7c967d45
https://doi.org/10.1016/s0895-4356(98)00043-2

Zobrazit plný text záznamu

Faculty Roundtable Discussion

Autor: Judith S. Currier, Kevin R. Frost, Mark Holodniy, David Rubin, Laura Pinsky, Jay Franklin Dobkin, Calvin J. Cohen, Paul Bellman, Amy Leonard, Samuel Merrick, Wafaa El-Sadr, Michael S. Saag, Anita Vaughn

Publikováno v: Scopus-Elsevier

one of the most frequently asked. What do you start treatment with? Suppose a new patient, with no retroviral history, comes to you with a CD4 count between 400 and 500 and a viral load of 10,000 to 15,000 copies. DR. SAAG: There is more to consider

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08cec95f9be2f6836eea6b3aa6f2fc46
https://doi.org/10.1089/apc.1998.12.543

Zobrazit plný text záznamu

Ensuring the safety of HIV/AIDS generics

Autor: Kevin R. Frost

Publikováno v: The Lancet. 365:1290-1291

Welcome news on the international HIV/AIDS front arrived recently when the US Food and Drug Administration (FDA) approved Aspen Pharmacare’s triple-antiretroviral regimen. Tentative FDA approval for this South African company qualifies its triple c

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23be6c2ef9a134146bbab3b4580a4675
https://doi.org/10.1016/s0140-6736(05)61007-0

Zobrazit plný text záznamu

Ported speaker enclosure of a protable computer

Autor: Dan V. Forlenza, Greg B Memo, Kevin R. Frost, Mitchell A Markow

Publikováno v: The Journal of the Acoustical Society of America. 119:1302

A portable computer provides a modular ported speaker enclosure independent of the portable computer surfaces of the portable computer. The speaker enclosure can include a speaker enclosure top and a speaker enclosure base. A plurality of ports are f

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::6d14b3222e763bbf580d1894a947b444
https://doi.org/10.1121/1.2185023

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání